Want to see MWAI full AI Analyst Report?
MedWellAI (MWAI) AI Stock Analysis
Top Page
MedWellAI
(Other OTC:MWAI)
The score is primarily held down by weak financial performance—sharp revenue contraction, ongoing large losses, continued cash burn, and negative equity that elevates solvency and financing risk. Technicals also lean bearish with the price below key moving averages and negative MACD, while valuation support is limited because losses make the negative P/E less informative and no dividend yield is available.
MedWellAI (MWAI) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $1.95M
- Dividend Yield
- ―
- Average Volume (3M)
- 3,517
- Price to Earnings (P/E)
- -0.6
- Beta (1Y)
- 0.82
- Revenue Growth
- -5.68%
- EPS Growth
- 60.23%
- Country
- US
- Employees
- 5
- Sector
- Financial
- Sector Strength
- 68
- Industry
- Financial - Capital Markets
MedWellAI Business Overview & Revenue Model
Company Description
MedWellAI Inc., through its subsidiary, develops, acquires, operates, and invests in businesses. It provides AI-driven healthcare and wellness solutions. The company also offers a B2B e-commerce platform for distributing pharmaceutical products, part...
MedWellAI Financial Statement Overview
Summary
Financial performance is weak: revenue is highly volatile and fell sharply in the latest year, the company remains deeply unprofitable with persistently negative margins, and operating/free cash flow are consistently negative. The balance sheet adds significant risk due to sustained negative shareholders’ equity, indicating strained solvency and limited financial flexibility.
Income Statement
18Very NegativeBalance Sheet
12Very NegativeCash Flow
15Very Negative| Breakdown | TTM | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 527.86K | 527.86K | 594.77K | 5.86M | 5.86M | 3.86M |
| Gross Profit | 349.18K | 496.83K | 586.67K | 1.93M | 1.93M | 1.16M |
| EBITDA | -1.16M | -1.16M | -2.87M | -8.61M | -21.59M | 1.07M |
| Net Income | -1.59M | -1.59M | -3.61M | -11.52M | -11.52M | -565.51K |
Balance Sheet | ||||||
| Total Assets | 140.45K | 140.45K | 805.50K | 3.94M | 6.59M | 16.28M |
| Cash, Cash Equivalents and Short-Term Investments | 86.22K | 86.22K | 401.31K | 57.81K | 258.00K | 490.28K |
| Total Debt | 500.00K | 500.00K | 604.27K | 500.00K | 500.00K | 385.44K |
| Total Liabilities | 7.96M | 7.96M | 3.14M | 7.81M | 7.10M | 5.69M |
| Stockholders Equity | -7.98M | -7.98M | -2.50M | -3.87M | -509.88K | 10.59M |
Cash Flow | ||||||
| Free Cash Flow | -392.75K | -315.09K | -937.55K | -4.13M | -3.73M | -9.88M |
| Operating Cash Flow | -392.00K | -307.03K | -935.31K | -4.13M | -3.43M | 55.45K |
| Investing Cash Flow | -8,808 | -8,058 | 1.19M | 4.17M | 4.17M | -2.27M |
| Financing Cash Flow | 0 | 0 | 0 | -243.15K | -243.15K | 604.92K |
MedWellAI Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MWAI, the sentiment is Neutral. The current price of 0.30 is above the 20-day moving average (MA) of 0.30, below the 50-day MA of 0.31, and below the 200-day MA of 0.36, indicating a neutral trend. The MACD of -0.01 indicates Negative momentum. The RSI at 49.59 is Neutral, neither overbought nor oversold. The STOCH value of 95.83 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for MWAI.
MedWellAI Risk Analysis
MedWellAI disclosed 12 risk factors in its most recent earnings report. MedWellAI reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
0 New RisksMedWellAI Peers Comparison
Overall Rating
CSAI42Neutral
HIT42Neutral- MWAI42Neutral
AIXI39Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 68Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
| CSAI | 42Neutral | $1.88M | -0.15 | -138.21% | ― | 117.68% | -0.39% |
| HIT | 42Neutral | $37.70M | -8.19 | -20.95% | ― | 22.98% | -362.10% |
| MWAI | 42Neutral | $1.94M | -0.65 | 21.06% | ― | -5.68% | 60.23% |
| AIXI | 39Underperform | $1.55M | -0.00 | 78.82% | ― | -96.21% | -112.17% |
* Financial Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| MWAI | Medwellai, Inc. | 0.30 | -0.46 | -60.77% | |
| AIXI | Xiao-I Corp. ADR | 2.75 | -132.29 | -97.96% | |
| SPPL | Simpple Ltd. | 2.32 | -3.86 | -62.46% | |
| HIT | Health In Tech, Inc. Class A | 0.58 | -2.12 | -78.63% | |
| CSAI | Cloudastructure, Inc. Class A | 2.15 | -53.95 | -96.17% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 22, 2026